e Urosepsis can progress toward severe sepsis, septic shock, and, ultimately, death. Rapid antimicrobial susceptibility testing is crucial to decrease mortality and morbidity. This report shows that isothermal microcalorimetry can provide an antibiogram within 7 h with a sensitivity of 95% and specificity of 91% using Vitek-2 system as a reference. U rinary tract infections (UTIs) are the second-most-common type of infection. Patients at risk of urosepsis are those who are elderly, diabetic, immunocompromised, and with obstruction in the urinary tract. Urosepsis might progress to severe sepsis and septic shock, both associated with a high mortality rate ranging between 22% and 76% (1, 2). Treatment of urosepsis includes empirical broad-spectrum antimicrobial therapy and timely deescalation when antimicrobial susceptibility testing (AST) results become available (3-5). Identification of the pathogen and determination of its susceptibility patterns take at least 48 h on average. Moreover, several methods currently used for AST have additional drawbacks (6, 7). Isothermal microcalorimetry (IMC) that measures metabolic heat production by microbes was recently identified as a promising near-future alternative to conventional methods for AST (6, 7). As urosepsis is virtually always accompanied by UTIs with a high density of uropathogens, urine specimens could be used directly for AST by IMC. Other arguments also advocate such an approach. First, urine is a potent growth medium (8). Second, in 95% of uroseptic cases, urine culture and positive blood culture lead to similar pathogen isolation results (9). And third, polymicrobial infections are rare in bacteremic UTIs (5% to 11%), thus ensuring that only the targeted pathogen is investigated (10, 11). Before introducing IMC for AST in the clinic or performing a clinical study, one needs to determine its sensitivity, specificity, and accuracy. For this study, we used 15 uropathogens (9 Escherichia coli, 3 Enterococcus faecalis, and 3 Enterococcus faecium) previously identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Susceptibility patterns were obtained by the Vitek-2 system (an automated system for AST). Among the 9 E. coli strains, 3 were sensitive to all antimicrobials tested, 3 were resistant to at least ciprofloxacin, and 3 strains were extended-spectrum-beta-lactamase (ESBL)-producing strains. Among enterococci, all E. faecium strains and one E. faecalis strain were resistant to amoxicillin. Cultures of these strains were diluted in modified artificial urine (12) to obtain an optical density (OD) of 0.1. A 10-l volume of this dilution was added to a 4-ml microcalorimetric vial prefilled with 3 ml of artificial urine with or without antimicrobial (using the EUCAST guidelines for breakpoint concentration). For AST with E. coli, the following antimicrobials and their respective concentrations were used: ciprofloxacin at 0.5 mg/ liter, cotrimoxazole at 2 mg/liter, ceftriaxone at 1 mg/liter, amoxicillin at 8 mg/liter, piperacillin at 8 mg/liter, and ertapenem at 0.5 mg/liter. For enterococci, only amoxicillin at 4 mg/liter and cotrimoxazole at 0.03 mg/liter were tested. After inoculation, the vials were sealed and introduced into the microcalorimeter (TAM48; Waters/TA). The metabolic heat production rate was recorded until the value nearly returned to the baseline. Data were extracted and the maximum growth rate (), the lag-phase duration (), and the total heat produced (Q) were calculated as described in reference 13. An inhibition index was calculated as follows: (1) where I is the percent inhibition index. The s and c indices indicate samples and controls, respectively. The results were obtained in 7 h, including 25 to 30 min for sample handling and preparation, 6 h for measurements, and, finally, 30 min for curve fitting and data processing using the R statistical package (14, 15). The calculated inhibitions were concordant with the Vitek-2 system results in 95% of cases. Similarly, IMC results were confirmed by a final OD measurement of the microcalorimetric ampoule content after 48 h (Table 1) . For ciprofloxacin and cotrimoxazole, there was a clearcut difference (Mann-Whitney test; P Ͻ 0.05) in the inhibition indices of susceptible strains (showing very little growth) and resistant strains (showing rapid growth) (Fig. 1) . On the other hand, for beta-lactams (amoxicillin, ceftriaxone, and piperacillin), the inhibition index calculated for susceptible strains using IMC was lower ( Fig. 1 ) but still exhibited a significant difference from the indices determined for resistant strains in all cases (Mann-Whitney test; P Ͻ 0.05). This is explained by the mode and speed of action of this antimicrobial class. Early in vitro time-kill-curve studies showed that a decrease of CFU or OD after addition of
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